Growth hormone secretagogues: mechanism of action and use in aging (Q34035420)

30 July 2017

1 reference

title

Growth hormone secretagogues: mechanism of action and use in aging (English)

1 reference

30 July 2017

V L Fuh

1

1 reference

PubMed ID

10990440

30 July 2017

M A Bach

series ordinal

2

1 reference

30 July 2017

1 February 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

1 reference

30 July 2017

8

1 reference

30 July 2017

1

1 reference

30 July 2017

13-20

1 reference

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

A Study on the Regulation of Growth Hormone Release from the Pituitaries of Rats in Vitro*

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

In vitro characterization of four novel classes of growth hormone-releasing peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

A nonpeptidyl growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Physiology of growth hormone secretion during sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Neuroendocrine regulation of growth hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Effect of growth hormone (GH)-releasing peptide (GHRP) on the release of GH from cultured anterior pituitary cells in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Constitutive growth hormone secretion in sheep after hypothalamopituitary disconnection and the direct in vivo pituitary effect of growth hormone releasing peptide 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-d-Trp-Ala-Trp-d-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Central actions of peptide and non-peptide growth hormone secretagogues in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Regulation of growth hormone secretion by the growth hormone releasing hexapeptide (GHRP-6)

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

6 Factors controlling blood concentration of somatomedin C

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Comparative Effect of Galanin and Pyridostigmine on the Growth Hormone Response to Growth Hormone-Releasing Hormone in Normal Aged Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone replacement in healthy older men improves body composition but not functional ability

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone therapy for the elderly: the fountain of youth proves toxic

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

Variables determining the growth hormone response of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980317-1

7 January 2021

10.1016/S1096-6374(98)80317-1

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10990440